Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126340711 | 12634071 | 1 | I | 20160223 | 20160729 | 20160808 | 20160808 | EXP | AT-MYLANLABS-2016M1031994 | MYLAN | 0.00 | Y | 0.00000 | 20160808 | MD | AT | AT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126340711 | 12634071 | 1 | PS | SIMVASTATIN. | SIMVASTATIN | 1 | 20 MG, UNK | U | U | 90868 | 20 | MG | |||||||
| 126340711 | 12634071 | 2 | SS | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | UNK | U | U | 0 | |||||||||
| 126340711 | 12634071 | 3 | SS | ALNA | TAMSULOSIN HYDROCHLORIDE | 1 | UNK | U | U | 0 | |||||||||
| 126340711 | 12634071 | 4 | SS | THROMBO ASS | ASPIRIN | 1 | UNK | U | U | 0 | |||||||||
| 126340711 | 12634071 | 5 | SS | HEPARIN | HEPARIN SODIUM | 1 | UNK | U | U | 0 | |||||||||
| 126340711 | 12634071 | 6 | SS | ACEMIN /00011902/ | CHLORPROMAZINE HYDROCHLORIDE | 1 | UNK | U | U | 0 | |||||||||
| 126340711 | 12634071 | 7 | SS | NICOTINELL | NICOTINE | 1 | UNK | U | U | 0 | |||||||||
| 126340711 | 12634071 | 8 | SS | ELIQUIS | APIXABAN | 1 | 5 MG, BID | Y | U | 0 | 5 | MG | BID | ||||||
| 126340711 | 12634071 | 9 | C | VOLTAREN | DICLOFENAC SODIUM | 1 | UNK | U | 0 | ||||||||||
| 126340711 | 12634071 | 10 | C | XEFO | LORNOXICAM | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126340711 | 12634071 | 1 | Product used for unknown indication |
| 126340711 | 12634071 | 2 | Product used for unknown indication |
| 126340711 | 12634071 | 3 | Product used for unknown indication |
| 126340711 | 12634071 | 4 | Product used for unknown indication |
| 126340711 | 12634071 | 5 | Product used for unknown indication |
| 126340711 | 12634071 | 6 | Product used for unknown indication |
| 126340711 | 12634071 | 7 | Product used for unknown indication |
| 126340711 | 12634071 | 8 | Product used for unknown indication |
| 126340711 | 12634071 | 9 | Product used for unknown indication |
| 126340711 | 12634071 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126340711 | 12634071 | OT |
| 126340711 | 12634071 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126340711 | 12634071 | Cerebral ischaemia | |
| 126340711 | 12634071 | Cerebrovascular accident | |
| 126340711 | 12634071 | Dizziness | |
| 126340711 | 12634071 | Haemorrhage | |
| 126340711 | 12634071 | Headache |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126340711 | 12634071 | 8 | 201602 | 201607 | 0 |